Cyr61 Expression is associated with prognosis in patients with colorectal cancer

BMC Cancer

Volumn 14, Issue 1, 2014, Pages

  Jeong, Dongjun ^a   Heo, Suhak ^a   Sung Ahn, Tae ^a   Lee, Sookyoung ^a   Park, Soyoung ^a   Kim, Hyungjoo ^a   Park, Doosan ^a   Byung Bae, Sang ^a   Lee, Sung S ^a   Soo Lee, Moon ^a   Kim, Chang Jin ^a   Jun Baek, Moo ^a  

^a Soonchunhyang University   (South Korea)

Author keywords

Colorectal cancer; Cyr61; Immunohistochemistry; Prognosis

Indexed keywords

CYSTEINE RICH PROTEIN 61;

ADULT; AGED; ARTICLE; CANCER CELL; CANCER MORTALITY; CANCER PROGNOSIS; CANCER STAGING; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPHATIC INVASION; MAJOR CLINICAL STUDY; MALE; PROTEIN EXPRESSION; SURVIVAL TIME; TUMOR INVASION; VASCULAR INVASION; WESTERN BLOTTING; COLORECTAL TUMOR; GENE EXPRESSION; GENETICS; METABOLISM; METASTASIS; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; TUMOR CELL LINE;

AGED; CELL LINE, TUMOR; COLORECTAL NEOPLASMS; CYSTEINE-RICH PROTEIN 61; FEMALE; GENE EXPRESSION; HUMANS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM STAGING; PROGNOSIS;

EID: 84897573712     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-14-164     Document Type: Article

References (38)

1. Holbourn KP, Acharya KR, Perbal B. The CCN family of proteins: structure-function relationships. Trends BiochemSci 2008, 33:461-473.
2. Holloway SE, Beck AW, Girard L, Jaber MR, Barnett CC, Brekken RA, Fleming JB. Increased expression of Cyr61 (CCN1) identified in peritoneal metastases from human pancreatic cancer. J Am Coll Surg 2005, 200:371-377. 10.1016/j.jamcollsurg.2004.10.005, 15737847.
3. Xie D, Miller CW, O'Kelly J, Nakachi K, Sakashita A, Said JW, Gornbein J, Koeffler HP. Breast cancer. Cyr61 is overexpressed, estrogen-inducible, and associated with more advanced disease. J Biol Chem 2001, 276:14187-14194.
4. Sun ZJ, Wang Y, Cai Z, Chen PP, Tong XJ, Xie D. Involvement of Cyr61 in growth, migration, and metastasis of prostate cancer cells. Br J Cancer 2008, 99:1656-1667. 10.1038/sj.bjc.6604712, 2584944, 18941464.
5. Kassis JN, Virador VM, Guancial EA, Kimm D, Ho AS, Mishra M, Chuang EY, Cook J, Gius D, Kohn EC. Genomic and phenotypic analysis reveals a key role for CCN1 (CYR61) in BAG3-modulated adhesion and invasion. J Pathol 2009, 218:495-504. 10.1002/path.2557, 19402132.
6. Tsai MS, Bogart DF, Castaneda JM, Li P, Lupu R. Cyr61 promotes breast tumorigenesis and cancer progression. Oncogene 2002, 21:8178-8185. 10.1038/sj.onc.1205682, 12444554.
7. Gery S, Xie D, Yin D, Gabra H, Miller C, Wang H, Scott D, Yi WS, Popoviciu ML, Said JW, Koeffler HP. Ovarian carcinomas: CCN genes are aberrantly expressed and CCN1 promotes proliferation of these cells. Clin Cancer Res 2005, 11:7243-7254. 10.1158/1078-0432.CCR-05-0231, 16243794.
8. Babic AM, Kireeva ML, Kolesnikova TV, Lau LF. CYR61, a product of a growth factor-inducible immediate early gene, promotes angiogenesis and tumor growth. Proc Natl Acad Sci USA 1998, 95:6355-6360. 10.1073/pnas.95.11.6355, 27701, 9600969.
9. Lin MT, Zuon CY, Chang CC, Chen ST, Chen CP, Lin BR, Wang MY, Jeng YM, Chang KJ, Lee PH, Chen WJ, Kuo ML. Cyr61 induces gastric cancer cell motility/invasion via activation of the integrin/nuclear factor-kappaB/cyclooxygenase-2 signaling pathway. Clin Cancer Res 2005, 11:5809-5820. 10.1158/1078-0432.CCR-04-2639, 16115920.
10. Xie D, Yin D, Wang HJ, Liu GT, Elashoff R, Black K, Koeffler HP. Levels of expression of CYR61 and CTGF are prognostic for tumor progression and survival of individuals with gliomas. Clin Cancer Res 2004, 10:2072-2081. 10.1158/1078-0432.CCR-0659-03, 15041728.
11. Xie D, Yin D, Tong X, O'Kelly J, Mori A, Miller C, Black K, Gui D, Said JW, Koeffler HP. Cyr61 is overexpressed in gliomas and involved in integrin-linked kinase-mediated Akt and beta-catenin-TCF/Lef signaling pathways. Cancer Res 2004, 64:1987-1996. 10.1158/0008-5472.CAN-03-0666, 15026334.
12. Pilarsky CP, Schmidt U, Eissrich C, Stade J, Froschermaier SE, Haase M, Faller G, Kirchner TW, Wirth MP. Expression of the extracellular matrix signaling molecule Cyr61 is downregulated in prostate cancer. Prostate 1998, 36:85-91. 10.1002/(SICI)1097-0045(19980701)36:2<85::AID-PROS3>3.0.CO;2-D, 9655260.
13. Sampath D, Zhu Y, Winneker RC, Zhang Z. Aberrant expression of Cyr61, a member of the CCN (CTGF/Cyr61/Cef10/NOVH) family, and dysregulation by 17 beta-estradiol and basic fibroblast growth factor in human uterine leiomyomas. J Clin Endocrinol Metab 2001, 86:1707-1715.
14. Tong X, Xie D, O'Kelly J, Miller CW, Muller-Tidow C, Koeffler HP. Cyr61, a member of CCN family, is a tumor suppressor in non-small cell lung cancer. J Biol Chem 2001, 276:47709-47714. 10.1074/jbc.M107878200, 11598125.
15. Tong X, O'Kelly J, Xie D, Mori A, Lemp N, McKenna R, Miller CW, Koeffler HP. Cyr61 suppresses the growth of non-small-cell lung cancer cells via the beta-catenin-c-myc-p53 pathway. Oncogene 2004, 23:4847-4855. 10.1038/sj.onc.1207628, 15077166.
16. Chien W, Kumagai T, Miller CW, Desmond JC, Frank JM, Said JW, Koeffler HP. Cyr61 suppresses growth of human endometrial cancer cells. J Biol Chem 2004, 279:53087-53096. 10.1074/jbc.M410254200, 15471875.
17. Korean national cancer information center. Cancer incidence. http://www.cancer.go.kr/ncic/cics_f/01/011/index.html.
18. Issa JP. Colon cancer: it's CIN or CIMP. Clin CancerRes 2008, 14:5939-5940.
19. McHugh SM, O'Donnell J, Gillen P. Genomic and oncoproteomic advances in detection and treatment of colorectal cancer. World J Surg Oncol 2009, 7:36. 10.1186/1477-7819-7-36, 2667518, 19338662.
20. Lau LF. CCN1/CYR61: the very model of a modern matricellular protein. Cell Mol Life Sci 2011, 68(19):3149-3163. 10.1007/s00018-011-0778-3, 3651699, 21805345.
21. Yang GP, Lau LF. Cyr61, product of a growth factor inducible immediate early gene, is associated with the extracellular matrix and the cell surface. Cell Growth Differ 1991, 2:351-357.
22. Kireeva ML, Mo F-E, Yang GP, Lau LF. Cyr61, product of a growth factor-inducible immediate-early gene, promotes cell proliferation, migration, and adhesion. Mol Cell Biol 1996, 16:1326-1334. 231116, 8657105.
23. Kireeva ML, Lam SCT, Lau LF. Adhesion of human umbilical vein endothelial cells to the immediate-early gene product Cyr61 is mediated through integrin alphavbeta3. J Biol Chem 1998, 273:3090-3096. 10.1074/jbc.273.5.3090, 9446626.
24. Lau LF, Lam SC. The CCN family of angiogenic regulators: the integrin connection. Exp Cell Res 1999, 248:44-57. 10.1006/excr.1999.4456, 10094812.
25. Lin BR, Chang CC, Chen LR, Wu MH, Wang MY, Kuo IH, Chu CY, Chang KJ, Lee PH, Chen WJ, Kuo ML, Lin MT. Cysteine-rich 61 (CCN1) enhances chemotactic migration, transendothelial cell migration, and intravasation by concomitantly up-regulating Chemokine receptor 1 and 2. Mol Cancer Res 2007, 5:1111-1123. 10.1158/1541-7786.MCR-06-0289, 18025257.
26. Folkman J. Angiogenesis. Annu Rev Med 2006, 57:1-18. 10.1146/annurev.med.57.121304.131306, 16409133.
27. Monnier Y, Farmer P, Bieler G, Imaizumi N, Sengstag T, Alghisi GC, Stehle JC, Ciarloni L, Andrejevic-Blant S, Moeckli R, Mirimanoff RO, Goodman SL, Delorenzi M, Rüegg C. CYR61 and avb5 integrin cooperate to promote invasion and metastasis of tumors growing in preirradiated stroma. Cancer Res 2008, 68:7323-7331. 10.1158/0008-5472.CAN-08-0841, 18794119.
28. Tsai MS, Hornby AE, Lakins J, Lupu R. Expression and function of CYR61, an angiogenic factor, in breast cancer cell lines and tumor biopsies. Cancer Res 2000, 60:5603-5607.
29. Xie D, Nakachi K, Wang H, Elashoff R, Koeffler HP. Elevated levels of connective tissue growth factor, WISP-1, and CYR61 in primary breast cancers associated with more advanced features. Cancer Res 2001, 61:8917-8923.
30. Jiang WG, Watkins G, Fodstad O, Douglas-Jones A, Mokbel K, Mansel RE. Differential expression of the CCN family members Cyr61, CTGF and Nov in human breast cancer. Endocr Relat Cancer 2004, 11:781-791. 10.1677/erc.1.00825, 15613452.
31. O'Kelly J, Chung A, Lemp N, Chumakova K, Yin D, Wang HJ, Said J, Gui D, Miller CW, Karlan BY, Koeffler HP. Functional domains of CCN1 (Cyr61) regulate breast cancer progression. Int J Oncol 2008, 33:59-67.
32. D'Antonio KB, Toubaji A, Albadine R, Mondul AM, Platz EA, Netto GJ, Getzenberg RH. Extracellular matrix associated protein CYR61 is linked to prostate cancer development. J Urol 2010, 183:1604-1610. 10.1016/j.juro.2009.12.006, 3349619, 20172544.
33. Goodwin CR, Lal B, Zhou X, Ho S, Xia S, Taeger A, Murray J, Laterra J. Cyr61 mediates hepatocyte growth factor dependent tumor cell growth, migration, and Akt activation. Cancer Res 2010, 70:2932-2941. 10.1158/0008-5472.CAN-09-3570, 2848876, 20233866.
34. Kok SH, Chang HH, Tsai JY, Hung HC, Lin CY, Chiang CP, Liu CM, Kuo MY. Expression of Cyr61 (CCN1) in human oral squamous cell carcinoma: an independent marker for poor prognosis. Head Neck 2010, 32:1665-1673. 10.1002/hed.21381, 20848406.
35. Ladwa R, Pringle H, Kumar R, West K. Expression of CEGF and Cyr61 in colorectal cancer. J Clin Pathol 2011, 64(1):58-64. 10.1136/jcp.2010.082768, 21081514.
36. Jun JI, Lau LF. The matricellular protein CCN1/CYR61 induces fibroblast senescence and restricts fibrosis in cutaneous wound healing. Nat Cell Biol 2010, 12:676-685. 10.1038/ncb2070, 2919364, 20526329.
37. Feng P, Wang B, Ren EC. Cyr61/CCN1 is a tumor suppressor in human hepatocellular carcinoma and involved in DNA damage response. Int J Biochem Cell Biol 2008, 40:98-109. 10.1016/j.biocel.2007.06.020, 17698398.
38. Dobroff AS, Wang H, Melnikova VO, Villares GJ, Zigler M, Huang L, Bar-Eli M. Silencing cAMP-response element binding protein (CREB) identifies cysteine-rich protein 61 (CYR61) as a tumor suppressor gene in melanoma. J Biol Chem 2009, 284:26194-26206. 10.1074/jbc.M109.019836, 2758018, 19632997.